Table 1 Description of the number of Brazilian women, the target population for breast cancer screening, mammograms performed and their direct costs, and chemotherapy costs in advanced and localized disease from January 2017 to June 2021
2017 | 2018 | 2019 | 2020 | 2021b | |
|---|---|---|---|---|---|
Total number of women | 105,189,655 | 105,996,973 | 106,777,332 | 107,530,666 | 108,256,605 |
The target population for breast cancer screening (women 50 to 69 years of age) | 19,584,342 | 20,118,371 | 20,636,636 | 21,140,958 | 21,630,107 |
The number of mammograms performed in the target population | 2,643,139 | 2,511,707 | 2,509,728 | 1,469,698 | 842,092 |
The mammograms performed rate per target population for breast cancer screening (percentage of coverage) | 13.50% | 12.48% | 12.16% | 6.95% | 3.89% |
The total direct cost of mammograms performeda | 121,099,628.00 | 114,909,231.00 | 114,951,184.00 | 67,146,609.00 | 38,867,609.00 |
The total direct cost of chemotherapy in localized disease (Stage I and II)a | 105,257,332.00 | 108,222,407.00 | 111,462,939.00 | 113,098,846.00 | 54,973,267.00 |
The total direct cost of chemotherapy in advanced disease (Stages III and IV)a | 378,953,806.00 | 409,508,569.00 | 437,992,093.00 | 465,706,966.00 | 248,566,856.00 |
The direct cost rate of breast cancer screening per direct cost with chemotherapy | 25.01% | 22.19% | 20.92% | 11.60% | 12.80% |
The direct cost rate of advanced disease treatment per direct cost with chemotherapy | 78.26% | 79.10% | 79.71% | 80.46% | 81.89% |